Lower urinary tract function after intra-arterial chemotherapy with concurrent pelvic radiotherapy for invasive bladder cancer

Japanese Journal of Clinical Oncology

Volumn 29, Issue 10, 1999, Pages 479-484

  Sekido, Noritoshi ^a   Miyanaga, Naoto ^a   Kikuchi, Koji ^a   Takeshima, Hitoshi ^a   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bladder cancer; Chemotherapy; Radiation; Urodynamic study

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; METHOTREXATE;

AGED; ARTICLE; BLADDER TUMOR; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PELVIS; RADIATION EXPOSURE; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT; URODYNAMICS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHOTREXATE; MIDDLE AGED; PELVIS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; URINARY TRACT; URODYNAMICS;

EID: 0033201660     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.10.479     Document Type: Article

References (17)

1. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, editors. Campbell's Urology, 7th. ed., Vol. 3. Philadelphia: WB Saunders 1997;2327-410.
2. Eapen L, Stewart D, Danjoux C, Genest P, Futter N, Moors D, et al. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol 1989;7:230-5.
3. Miyanaga, N, Akaza H, Ohtani M, Takeshima H, Uchida K, Kikuchi K, et al. A bladder-sparing regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer. J Urol 1996;155:664A.
4. Fishman IJ, Shabsigh R, Kaplan AL. Lower urinary tract dusfunction after radical hysterectomy for carcinoma of cervix. Urology 1986;28:462-8.
5. Chancellor MB, Rivas DA. Similarity of the American Urologic Association symptom index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperrefiexia without outlet obstruction. Br J Urol 1994;74:200-3.
6. Abrams P, Blaivas JG, Santon SL, Andersen JT. The standardisation of terminology of lower urinary tract function. Scand J Urol Nephrol 1988;114:1-15.
7. Lundbeck F, Oussoren Y, Stewart FA. Early and late damage in the mouse bladder after radiation combined with cyclophosphamide or cisplatinum, evaluated by two different functional assays. Acta Oncol 1993;32:679-87.
8. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205-9.
9. Castellanos AM, Glass JP, Alfred Yung WK. Regional nerve injury after intra-arterial chemotherapy. Neurology 1987;37:834-7.
10. Richardson P, Cantwell BMJ. Autonomic neuropathy after cisplatin based chemotherapy. Br Med J 1990;300:1466-7.
11. Iglicki, F, Coffin B, Ille O, Flourie B, Amarenco G, Lemann M, et al. Fecal incontinence after pelvic radiotherapy: evidence for a lumbosacral plexopathy. Dis Colon Rectum 1996,39:465-7.
12. LoMonaco, M, Milone M, Batocchi, AP, Padua L, Restuccia D, Tonali P. Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol 1992;239:199-204.
13. Antonakopoulos GN, Hicks RM, Hamilton E. Early and late morphological changes (including carcinoma of the urothelium) induced by irradiation of the rat urinary bladder. Br J Cancer 1982;46:403-16.
14. Antonakopoulos GN, Hicks RM, Berry RJ. The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol 1984;143:103-I6.
15. Lundbeck R, Overgaard J. Early and late changes in the normal mouse bladder reservoir function due to irradiation and cis-DDP. Br J Cancer 1992;66:99-105.
16. Brading AF. Myogenic basis for the overactive bladder. Urology 1997;50(Suppl):57-67.
17. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997;50(Suppl):36-52.